Dark Forest Capital Management LP Vertex Pharmaceuticals Inc Transaction History

Dark Forest Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $4,464 - $5,558	-19 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $3,764 - $4,436	17 Added 850.0%	19 $5,000
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $23,188 - $29,271	-131 Reduced 98.5%	2 $0
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $24,124 - $26,997	133 New	133 $24,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.